Cited 0 times in

Performance evaluation of the Vitros anti-hepatitis C virus antibody assay for use in clinical laboratories.

Title
Performance evaluation of the Vitros anti-hepatitis C virus antibody assay for use in clinical laboratories.
Authors
Yongjung Park;Yoonmi Seok;Hyon-Suk Kim;Jonghyeon Choi
Issue Date
2012
Journal Title
Clinical Biochemistry
ISSN
0009-9120
Citation
Clinical Biochemistry, Vol.45(1-2) : 175~177, 2012
Abstract
OBJECTIVES: We evaluated the performance of Vitros anti-HCV assay. DESIGN AND METHODS: Precision performance was assessed for 20 days. A total of 1011 sera were tested for anti-HCV with Vitros and Elecsys assays. Specimens positive for any of the two assays were retested with Architect assay. Discrepant results were evaluated with recombinant immunoblot assay (RIBA) and HCV RNA quantification. RESULTS: Total imprecision of Vitros assay was 11.6% and 3.3% CV for negative and positive QC. Among the 1011 sera, 17 showed discrepant results between the three assays. Six were positive and three negative for RIBA. HCV RNA was not detected from all discrepant cases. Sensitivity and specificity were 99.5% and 99.5% for the Vitros, and 100.0% and 99.9% for the Elecsys assay. CONCLUSIONS: Sensitivities and specificities of the anti-HCV assays were sufficiently high for use in clinical laboratories, but retesting of weak positive results may be necessary.
URI
http://www.sciencedirect.com/science/article/pii/S0009912011027068

http://ir.ymlib.yonsei.ac.kr/handle/22282913/90004
DOI
10.1016/j.clinbiochem.2011.10.020
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Laboratory Medicine
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse